New rules make it easier for FDA to crack down on unscrupulous stem cell providers, doctors hope

New FDA rules aim to crack down on false and misleading claims by businesses trying to sell unproven, unregulated stem cell therapies. Investigative Reporter Katie LaGrone explains.